SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

Cancer’s future may lie in combination therapy—pairing treatments to outsmart tumors, boost survival, and bring new hope ...

Newer treatments and expanded screening are allowing more people to live for many years after cancer treatment, a welcome ...

A new study reveals personalized treatment strategies for HER2-negative breast cancer, optimizing antibody-drug conjugate sequencing based on tumor characteristics.

Jessie J discussed losing time with her 2-year-old son, Sky, amid her breast cancer journey on a recent episode of the 'Great Company with Jamie Laing' podcast.

ANSWER: Gynecomastia is the growth of male breast tissue, specifically when not due to breast cancer. It can happen during ...

When Robert Stone thinks about what makes City of Hope stand apart, it's the people. He recalls a patient who stopped him, a ...

Novocure (Nasdaq:NVCR) announced today that it submitted an FDA premarket approval (PMA) application for its tumor-treating ...

The Waltham company experienced a major setback earlier this year with its lead cancer treatment, resulting in widespread ...

The biotechnology company said late Monday that Health Canada issued a Notice of Compliance with Conditions for its treatment, Amtagvi, for adult patients with unresectable or metastatic melanoma that ...